GLP-1 therapies are a cornerstone for the management of type 2 diabetes, supporting glycemic control and improving ...

Leadership transition follows a year of doubled revenue and rising demand for low-carbon pavement preservation ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Judo Bio, a biotechnology company pioneering oligonucleotide medicines delivered to the kidney, today announced the company’s launch and $100 million in initial ...

Annovis is also seeking fresh capital while working to advance trials for both Alzheimer's and Parkinson's disease drugs.

Conversion of promissory notes into common stock removed $94.9 million in pro forma balance sheet liabilities. The converted common stock is included in the company’s total 165 million outstanding ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Most of Kelderman's pay was in ...

Abbott to lead the sustainable agriculture company through global growth as it transforms agriculture with its patented crop nutrition innovations and upends the $190B nitrogen market 1 Company ...

Henry Gosebruch, who has $3.5 billion in capital to deploy, is thinking broad as he steers the decades-old biotech out of ...

MINNEAPOLIS, Oct. 22, 2025 /PRNewswire/ -- Pivot Bio, one of the world's leading innovative agtech companies, is taking center stage this week at the Norman E. Borlaug International Dialogue, part of ...

Kronos Bio (NASDAQ:KRON) announced Wednesday its CFO Deborah Knobelman will become the company’s interim Chief Executive Officer on Dec. 3, replacing Norbert Bischofberger, who will resign as ...